2025 CHARACTERIZING UTERINE PERISTALSIS ACROSS THE MENSTRUAL CYCLE IN STAGE I-II VERSUS STAGE III-IV ENDOMETRIOSIS ·doi:10.1016/j.fertnstert.2025.07.916
2024 DISPROPORTIONALITY ANALYSIS WITH COMPARISON OF ELAGOLIX VERSUS LEUPROLIDE SAFETY IN WOMEN WITH ENDOMETRIOSIS USING DATA FROM THE FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) ·doi:10.1016/j.fertnstert.2024.07.297
other 2022 Isthmocele endometriosis: when two is definitely not better than one Fertility and sterility ·doi:10.1016/j.fertnstert.2022.04.011